Compare Pfizer with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs ABBOTT INDIA - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER ABBOTT INDIA PFIZER/
ABBOTT INDIA
 
P/E (TTM) x 39.6 58.6 67.6% View Chart
P/BV x 6.7 14.1 47.3% View Chart
Dividend Yield % 0.5 0.5 105.2%  

Financials

 PFIZER   ABBOTT INDIA
EQUITY SHARE DATA
    PFIZER
Mar-19
ABBOTT INDIA
Mar-19
PFIZER/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs3,8408,834 43.5%   
Low Rs2,0805,458 38.1%   
Sales per share (Unadj.) Rs455.01,731.1 26.3%  
Earnings per share (Unadj.) Rs93.8211.9 44.3%  
Cash flow per share (Unadj.) Rs109.4219.9 49.7%  
Dividends per share (Unadj.) Rs22.5065.00 34.6%  
Dividend yield (eoy) %0.80.9 83.6%  
Book value per share (Unadj.) Rs658.2945.2 69.6%  
Shares outstanding (eoy) m45.7521.25 215.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.54.1 157.6%   
Avg P/E ratio x31.633.7 93.6%  
P/CF ratio (eoy) x27.132.5 83.3%  
Price / Book Value ratio x4.57.6 59.5%  
Dividend payout %24.030.7 78.2%   
Avg Mkt Cap Rs m135,420151,848 89.2%   
No. of employees `0002.63.5 75.5%   
Total wages/salary Rs m3,2384,356 74.3%   
Avg. sales/employee Rs Th7,911.410,555.5 75.0%   
Avg. wages/employee Rs Th1,230.91,249.9 98.5%   
Avg. net profit/employee Rs Th1,630.71,292.2 126.2%   
INCOME DATA
Net Sales Rs m20,81536,786 56.6%  
Other income Rs m1,6741,133 147.8%   
Total revenues Rs m22,48937,919 59.3%   
Gross profit Rs m5,7126,047 94.5%  
Depreciation Rs m714169 421.9%   
Interest Rs m7323 324.0%   
Profit before tax Rs m6,5996,989 94.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,3092,485 92.9%   
Profit after tax Rs m4,2914,503 95.3%  
Gross profit margin %27.416.4 166.9%  
Effective tax rate %35.035.6 98.4%   
Net profit margin %20.612.2 168.4%  
BALANCE SHEET DATA
Current assets Rs m27,16727,610 98.4%   
Current liabilities Rs m8,9178,569 104.1%   
Net working cap to sales %87.751.8 169.4%  
Current ratio x3.03.2 94.6%  
Inventory Days Days6860 112.6%  
Debtors Days Days3027 109.9%  
Net fixed assets Rs m8,8621,057 838.5%   
Share capital Rs m458213 215.3%   
"Free" reserves Rs m29,65619,873 149.2%   
Net worth Rs m30,11320,086 149.9%   
Long term debt Rs m250-   
Total assets Rs m39,40029,409 134.0%  
Interest coverage x91.5311.6 29.4%   
Debt to equity ratio x00-  
Sales to assets ratio x0.51.3 42.2%   
Return on assets %11.115.4 72.0%  
Return on equity %14.222.4 63.5%  
Return on capital %22.134.9 63.4%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m428369 116.1%   
Fx outflow Rs m7864,918 16.0%   
Net fx Rs m-358-4,549 7.9%   
CASH FLOW
From Operations Rs m9784,991 19.6%  
From Investments Rs m351-2,570 -13.7%  
From Financial Activity Rs m-1,099-1,428 76.9%  
Net Cashflow Rs m231993 23.2%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 63.9 75.0 85.2%  
Indian inst/Mut Fund % 7.5 7.9 94.9%  
FIIs % 4.9 0.1 4,900.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 17.1 138.6%  
Shareholders   85,207 18,270 466.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   DR. DATSONS LABS  DISHMAN PHARMA  TTK HEALTHCARE  JUBILANT LIFE SCIENCES  DIVIS LABORATORIES  

Compare PFIZER With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Flat; Sun Pharma and ITC Top Losers(09:30 am)

Asian stock markets are mixed today. The Nikkei 225 is flat while the Hang Seng is down 0.3%. The Shanghai Composite is trading up by 0.1%.

Related Views on News

DIVIS LABORATORIES at All Time High; BSE HEALTHCARE Index Up 0.7% (Market Updates)

Dec 16, 2019 | Updated on Dec 16, 2019

DIVIS LABORATORIES share price has hit an all time high at Rs 1,869 (up 1.4%). The BSE HEALTHCARE Index is up by 0.7%. Among the top gainers in the BSE HEALTHCARE Index today are DIVIS LABORATORIES (up 1.4%) and ABBOTT INDIA (up 3.4%). The top losers include AJANTA PHARMA and NATCO PHARMA .

PFIZER Announces Quarterly Results (2QFY20); Net Profit Up 61.0% (Quarterly Result Update)

Oct 29, 2019 | Updated on Oct 29, 2019

For the quarter ended September 2019, PFIZER has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 6 bn (up 9.1% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (1QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PFIZER has posted a net profit of Rs 1 bn (up 22.8% YoY). Sales on the other hand came in at Rs 5 bn (up 6.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

PFIZER Announces Quarterly Results (4QFY19); Net Profit Up 4.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, PFIZER has posted a net profit of Rs 1 bn (up 4.7% YoY). Sales on the other hand came in at Rs 5 bn (up 3.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

Use My Secret to Increase Your Trading Profits Today

Dec 10, 2019

What to do after every trade.

How We Made 14.64% Trading Profit in Just 2 Days

Dec 12, 2019

A high probability trade that worked to perfection for my subscribers.

Blue Chips Are Passe. Get into these Stocks for Outstanding Gains in 2020(Profit Hunter)

Dec 5, 2019

This corner of the market could provide more returns than blue chips in 2020.

Make the Most of the Smallcap Rebound with These Stocks(Profit Hunter)

Dec 3, 2019

Even amid a gloomy economic scenario, there are smallcaps that have grown earnings over last one and a half year and I believe these could be the strongest candidates for a smallcap rebound.

Stocks that Can Outperform No Matter what the RBI Does Today(The 5 Minute Wrapup)

Dec 5, 2019

I won't be surprised if these stocks repeat their 2002-2006 performance.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Dec 16, 2019 11:03 AM

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS